Constellation Pharmaceuticals Inc (CNST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Operating Expenses | 124,847 | 86,055 | 61,244 | 39,088 | 33,658 |
| Operating Income | -124,847 | -86,055 | -61,244 | -39,088 | -33,658 |
| Interest Expense | 2,862 | 2,115 | 228 | 901 | 1,345 |
| Other Income | 1,391 | 2,644 | 1,547 | 4,612 | 470 |
| Pre-tax Income | -126,318 | -85,526 | -59,925 | -35,377 | -34,533 |
| Income Tax | 39 | 24 | N/A | N/A | N/A |
| Net Income Continuous | -126,357 | -85,550 | -59,925 | -35,377 | -34,533 |
| Net Income | $-126,357 | $-85,550 | $-59,925 | $-35,377 | $-34,533 |
| EPS Basic Total Ops | -2.81 | -3.04 | -5.00 | -56.10 | -53.19 |
| EPS Basic Continuous Ops | -2.81 | -3.04 | -5.00 | -36.91 | -37.13 |
| EPS Diluted Total Ops | -2.81 | -3.04 | -5.00 | -56.10 | -53.19 |
| EPS Diluted Continuous Ops | -2.81 | -3.04 | -5.00 | -36.91 | -37.13 |
| EPS Diluted Before Non-Recurring Items | -2.81 | -3.04 | -5.00 | N/A | N/A |
| EBITDA(a) | $-124,351 | $-85,995 | $-60,682 | $-38,614 | $-33,455 |